 |
인쇄하기
취소
|
National health insurance to cover new rheumatism drug
The Ministry of Health and Welfare said Thursday that Janssen Korea’s rheumatism medication Simponi (golimumab) will be covered by national health insurance through the public hearing.
Simponi, the first once-monthly subcutaneous anti-TNF-alpha therapy, was approved by the Food and Drug Administration in August 2012 for the treatment of moderately to severely active rheumatoid arthritis, act...
Simponi, the first once-monthly subcutaneous anti-TNF-alpha therapy, was approved by the Food and Drug Administration in August 2012 for the treatment of moderately to severely active rheumatoid arthritis, act...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.